Abstract
The authors describe an Alberta family with levodopa-responsive parkinsonism without cerebellar abnormalities. Genetic testing showed expanded repeats for SCA-2; other mutations for parkinsonism were excluded. The expanded allele shows interruption of the CAG repeat with CAA. PET in two affected members showed reduced fluorodopa uptake in striatum and normal raclopride binding. Families with autosomal dominant, levodopa-responsive parkinsonism should be tested for the SCA-2 mutation.
Original language | English (US) |
---|---|
Pages (from-to) | 1625-1627 |
Number of pages | 3 |
Journal | Neurology |
Volume | 59 |
Issue number | 10 |
DOIs | |
State | Published - Nov 26 2002 |
ASJC Scopus subject areas
- Clinical Neurology